Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol

Represents second complex respiratory therapeutic product approval in Q4 2025BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE ...

How Back-to-Back RESTASIS and PROAIR Generics At Amneal Pharmaceuticals (AMRX) Has Changed Its Investment Story

Amneal Pharmaceuticals recently received U.S. FDA approvals for its generic versions of RESTASIS® (cyclosporine ophthalmic emulsion 0.05%) and PROAIR® HFA (albuterol sulfate inhalation aerosol 90 mcg) ...

Amneal to Participate in Upcoming Investor Conferences

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) today announced that Chirag Patel, Co-Chief Executive and President, and Tasos Konidaris, Chief Financial Officer, will participate in following upcoming ...
pharmaphorum

GSK says new inhaler will help slash its carbon footprint

GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...
TipRanks on MSN

Amneal Pharmaceuticals announces FDA approval for epinephrine injection vials

Amneal Pharmaceuticals (AMRX) announced that the FDA has approved the company’s epinephrine injection USP, 1 mg/mL, in single-dose vials and 1 ...
TipRanks on MSN

Amneal Pharmaceuticals announces results from Phase 4 ELEVATE-PD

Amneal Pharmaceuticals (AMRX) announced new positive interim results from its ongoing Phase 4 ELEVATE-PD study, presented at the Parkinson’s Study ...